ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

POLB Poolbeg Pharma Plc

12.80
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Poolbeg Pharma Plc LSE:POLB London Ordinary Share GB00BKPG7Z60 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 12.80 12.60 13.00 12.80 12.60 12.60 875,875 11:13:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -4.69M -0.0094 -13.62 64M
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 12.80p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 6.55p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £64 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -13.62.

Poolbeg Pharma Share Discussion Threads

Showing 2601 to 2625 of 3350 messages
Chat Pages: Latest  110  109  108  107  106  105  104  103  102  101  100  99  Older
DateSubjectAuthorDiscuss
18/10/2023
12:47
Well there ya have it.Almost back to where we started.
chica1
18/10/2023
09:38
Poolbeg Pharma has partnered with a Nasdaq-listed biopharma company on its oral delivery platformhttps://m.independent.ie/business/poolbeg-pharma-partners-with-nasdaq-listed-biopharma-company/a1741251095.html
burtond1
18/10/2023
07:11
Singers maintain their BUY recommendation and PT of 21p.
adorling
17/10/2023
15:48
I wouldn't imagine the rise today is sustainable.
Even jovial Jeremy seemed underwhelmed this morning


Would love to be wrong,

chica1
17/10/2023
13:23
Certainly not the show stopper that I thought it was when I saw the RNS! But the market has responded well regardless. If it can rise on an agreement like this, imagine what it can do on a polb001 licensing agreement!
discojames
17/10/2023
13:21
Maybe the amount of support in cash terms to get it to the clinic.
Share price reaction and lack of volume says it all.

chica1
17/10/2023
13:04
I don't know. The name of the partner is missing but other than that I don't know what they could have reasonably added. It's a collaboration or joint research agreement, not a licensing agreement. So Poolbeg get a bit of funding to work on using their delivery mechanism for a particular drug & target delivery site specified by the partner. If it doesn't work, then there will be some learnings which might help them do better next time. If it does work then it will act as proof of concept for the partner who might then be interested in a full licence agreement for the technology.

Whether it merited a full RNS at this stage, I'm not so sure, but it keeps them moving forward and gives them another shot at a licensing agreement should they not manage to find anyone to partner POLB001 in the relatively near term.

1gw
17/10/2023
12:49
Sounds like a press release penned by Our Mr.Friel.

The lack of detail is exasperating.

chica1
17/10/2023
11:15
Today's news is probably the reason that someone last week bought 1 million shares at 8p. In a half decent market, surely they would be a lot higher than they are now.Must be great value at 7.5p.
klosters65
17/10/2023
09:26
Maybe have a watch if these videos to expand on #POLB news Please see Vox & Proactive interviews following the release of today's RNS:https://twitter.com/PoolbegPharma/status/1714175552251142252https://www.voxmarkets.co.uk/articles/jeremy-skillington-of-poolbeg-pharma-discusses-their-nasdaq-partnership-for-development-581b7af/
burtond1
17/10/2023
08:50
Does not bother me.
arlington chetwynd talbott
17/10/2023
08:47
I think the lack of chatter says it all!
chica1
17/10/2023
07:58
Their partner is presumably being a bit coy at this stage of the game. Nothing wrong with that. This is good news.
arlington chetwynd talbott
17/10/2023
07:51
A Nasdaq listed company with what market cap?There are companies trading on the Nasdaq with similar market caps to Poolbeg.
If they're not going to tell us the Company they could at least give us a top range of how much the funding worth.

Not dishing it but hey its very vague!

chica1
17/10/2023
07:50
Very nice.
arlington chetwynd talbott
17/10/2023
07:12
Great news for #POLB this...They have signed a strategic collaboration agreement with a #Nasdaq listed #biopharma to develop an optimised #oraldrug for a metabolic condition using #POLB's licensed technologyThey are also optimistic that this can lead to a full licensing agreementhttps://www.londonstockexchange.com/news-article/POLB/poolbeg-partners-with-a-nasdaq-listed-biopharma/16169180
burtond1
14/10/2023
14:49
Register for the webinar mentioned in the previous post here:
timbo003
14/10/2023
10:57
ShareSoc Webinar with Poolbeg Pharma(LON:POLB)25/10/23 5pm. CEO Jeremy Skillington will share insights into the company’s strategies in infectious disease therapeutics and give an update on current performance and future plans. Register here: [...]
sharesoc
13/10/2023
13:51
Getting NT for anything more than 10k
mrs robinson
09/10/2023
08:05
A reminder for Jeremy Skillington's presentation at today's Drug Discovery World webinar:https://twitter.com/PoolbegPharma/status/1711260201095983330
burtond1
05/10/2023
15:07
I just bought some more at £0.0759 they are showing as a sell.

I think this share is company is going well, some positive news coming out.

joseph moran
05/10/2023
11:17
Thanks - a good read. Article by Amgen authors - they're obviously doing a lot of work in the AI area, and crying out for good data.
supernumerary
05/10/2023
09:53
Decent article. Good this for #POLB Insightful article on how #AI can help to speed up #drugdiscovery.The high quality & unique nature of human challenge trial data can power AI-enabled drugdiscovery to identify novel & unlock meaningful insights into human diseasehttps://www.nature.com/articles/d41586-023-02896-9
burtond1
04/10/2023
20:27
? Poolbeg Pharma #POLB is revolutionizing the biopharma landscape! Leveraging #AI, they're accelerating drug discovery and setting new standards in infectious disease treatment. Game-changer ?? #DrugDiscovery #InnovationInHealth #InvestingWisdom tinyurl.com/3vem9b9chttps://x.com/lemminginvestor/status/1709293600456974776?s=46
elrico
04/10/2023
17:21
Hotting up. Someone paid 8p for just over 1 million shares at 11:20 this morning.
klosters65
Chat Pages: Latest  110  109  108  107  106  105  104  103  102  101  100  99  Older